Delivery Order SPE2DB22D1106-SPE2DB25FEZU5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,389.52 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 13, 2025, with completion scheduled for August 14, 2025. This is a firm fixed-price, non-set-aside contract that represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be performed and delivered from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,298.15 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on July 29, 2025, with completion expected by July 30, 2025. This firm fixed price delivery order represents a continuation of the company's extensive pharmaceutical and medical supply support to federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,668.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,768.98 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 Sensors, with an ultimate completion date of August 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $2,459.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 18, 2025, with completion targeted for July 21, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical and medical...
- The Defense Logistics Agency awarded a $4,027.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026. The sensors will be delivered to the...
- The Defense Logistics Agency awarded a $5,695.80 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a child delivery order under a larger contract vehicle. The sensors will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,988.34 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- The Defense Logistics Agency awarded a $3,172.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZU5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,841.04 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement with place of performance in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for continuous glucose monitoring sensors supports military medical supply chain requirements and demonstrates the vendor's role in fulfilling diverse pharmaceutical and medical device needs across the Defense Health Agency and other government healthcare systems. The firm's extensive portfolio of competitively awarded contracts with DLA reflects its significant capabilities in meeting federal procurement standards across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/25/25 |